In August 2016, pharmaceutical company Mylan became the latest health company to fall under fire for price gouging.

Over the course of seven years, they'd carefully managed to inflate the list price of EpiPen by nearly 500%, along with price-hikes on more than 30 other products too. That's pretty absurd, considering that some people, including fellow pharmaceutical-makers, say EpiPen ingredients are inexpensive and the pen can cost less than $20 to make. Plus, EpiPen already accounts for 40% of Mylan's operating profits.

At the height of this debacle, Mylan CEO Heather Bresch spoke with CNBC to offer insights on the inner workings of the pharmaceutical industry. And her answers actually revealed a lot about health care in America.

Keep Reading Show less
Family

Kim Kardashian, former breaker of the Internet and star of "That Show You Watch on the Treadmill," is pregnant.

But will she get her baby body back??? AMERICA NEEDS TO KNOW!!!

Keep Reading Show less
More